NOS2-deficient mice with hypoxic necrotizing lung lesions predict outcomes of tuberculosis chemotherapy in humans-Reference-Cited by-同舟云学术

NOS2-deficient mice with hypoxic necrotizing lung lesions predict outcomes of tuberculosis chemotherapy in humans

Published:2017-08-18 Issue:1 Volume:7 Page:
ISSN:2045-2322
Container-title:Scientific Reports
language:en
Short-container-title:Sci Rep

Author:

Gengenbacher Martin,Duque-Correa Maria A.,Kaiser Peggy,Schuerer Stefanie,Lazar Doris,Zedler Ulrike,Reece Stephen T.,Nayyar Amit,Cole Stewart T.,Makarov Vadim,Barry III Clifton E.,Dartois Véronique,Kaufmann Stefan H. E.^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/s41598-017-09177-2.pdf

Reference64 articles.

1. WHO. Global Tuberculosis Report 2015, Geneva (2015).

2. Gengenbacher, M. & Kaufmann, S. H. E. Mycobacterium tuberculosis: success through dormancy. FEMS Microbiol Rev. 36, 514–532 (2012).

3. Ulrichs, T. & Kaufmann, S. H. E. New insights into the function of granulomas in human tuberculosis. J. Pathol. 208, 261–269 (2006).

4. Barry, C. E. III et al. The spectrum of latent tuberculosis: rethinking the biology and intervention strategies. Nat. Rev Microbiol. 7, 845–855 (2009).

5. Lin, P. L. et al. Sterilization of granulomas is common in active and latent tuberculosis despite within-host variability in bacterial killing. Nat. Med. 20, 75–79 (2014).

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The clinical-stage drug BTZ-043 accumulates in tuberculosis lesions and efficiently acts against Mycobacterium tuberculosis;2023-02-28

2. Early experience of delamanid in extensively drug-resistant pulmonary tuberculosis;Lung India;2023

3. Mouse Models for Mycobacterium tuberculosis Pathogenesis: Show and Do Not Tell;Pathogens;2022-12-28

4. NOS2/miR-493-5p Signaling Regulates in the LPS-Induced Inflammatory Response in the RAW264.7 Cells;Biochemical Genetics;2022-11-30

5. Novel Regimens of Bedaquiline-Pyrazinamide Combined with Moxifloxacin, Rifabutin, Delamanid and/or OPC-167832 in Murine Tuberculosis Models;Antimicrobial Agents and Chemotherapy;2022-04-19